📰 Wize Pharma News
Wize Pharma News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Wize Pharma. Real-time updates on events, politics, business and more.
June 8, 2023
The first Israeli biotech company, where he served as Director of R&D from 1980 to 1987. During his managerial career Dr. Havron was directly involved in the multi-disciplinary development of many... | June 8, 2023
October 11, 2022
Vertua Limited (NSX:VER) purses unique investment opportunities.
May 20, 2021
Share this article Share this article ResearchAndMarkets.coms offering. This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) provides insights across retinal diseases, viral and non-viral vector platforms for gene therapies, allogeneic cell therapy, bone repair, gluten antigen-specific drug therapy for Celiac disease, plant-based anti-cancer agents, and food colors. Further, PCR-free whole genome sequencing, oral protein-drug delivery technology for insulin, a...
May 5, 2021
Pharma Leader Series: Top 50 Ophthalmic Drug Manufacturers Market Report 2021-2031 In-depth Analysis of Top 50 Ophthalmic Drug Manufacturers: Capabilities, Results, Competition and Sales Potentials Visiongain has published a new Pharma Leader Series report on Top 50 Ophthalmic Drug Manufacturers Market Report 2021-2031. May 05, 2021 10:45 ET | Source: ReportLinker ReportLinker Lyon, FRANCE New York, May 05, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com...
February 17, 2021
Wize Pharma set for switch to Bitcoin mining Wize Pharma has spun off its ophthalmology drug development activities, and will begin to mine digital currencies in another month through Cosmos. Wize Pharma (OTCQB: WIZP), from Hod Hasharon, has reported that it has met all the preconditions for implementing the offer to purchase the shares of Australian bitcoin miner Cosmos Capital Ltd. Wize Pharma expects to complete the purchase of the shares by March 9, 2021. One of the conditions was that the ...
February 16, 2021
Wize Pharmas Takeover Offer for Cosmos Capital Declared Unconditional USA - English News provided by Share this article Share this article HOD HASHARON, Israel, Feb. 16, 2021 /PRNewswire/ -- Wize Pharma, Inc. (OTCQB: WIZP), a clinical-stage biopharmaceutical company focused on the treatment of ophthalmic disorders, today announced that it has declared its previously announced off-market takeover offer ("Offer") for all of the ordinary shares in Cosmos Capital Limited, a leading digital infrastr...
January 11, 2021
Vertua Limited (NSX:VERA) Investment - Cosmos Capital Investment - Cosmos CapitalSydney, Jan 8, 2021 AEST (ABN Newswire) - Vertua Limited ( NSX:VERA) refers to previous disclosures about its shareholding in Cosmos Capital Limited (Cosmos), a leading Digital Infrastructure and Bitcoin Mining investment. Vertua holds 400,000 fully paid ordinary shares in Cosmos representing approximately 5.2% of Cosmos issued capital. Cosmos is an unlisted public company. James Manning is a shareholder and direc...
January 1, 2021
Wize Pharma merges with Australian Bitcoin miner Cosmos The Israeli biopharmaceutical company will spin off its drug development activity and focus on Bitcoin mining. Israeli clinical stage biopharmaceutical company Wize Pharma Inc. (OTCQB: WIZP) will merge with privately-held Australian digital currency infrastructure provider Cosmos Capital, in an all share deal, which will ultimately leave Cosmoss shareholders owning most of Wizes shares. Wize, which is controlled by Rimon Gold, the investme...